Search Within

Eric J Sherman

  1. "Heiko Schoder"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (12)
Groups
  1. Department of Medicine (30)
  2. Head and Neck Service (30)
  3. Molecular Imaging and Therapy Service (30)
  4. Radiology, Department of (30)
  5. Solid Tumor Oncology Division (30)
  6. Radiation Oncology, Department of (26)

More Groups

People
  1. Heiko Schoder (30)
  2. Nancy Lee (26)
  3. Nadeem Riaz (21)
  4. Richard Wong (21)
  5. John Humm (15)
  6. David Pfister (14)

More People

Years
  1. 2024 (8)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (13)
  2. Journal of Clinical Oncology (8)
  3. Oral Oncology (2)
  4. Annals of Oncology (1)
  5. Cancer (1)
  6. Head & Neck (1)

More Publications

Publishers
  1. Elsevier Inc. (15)
  2. American Society of Clinical Oncology (8)
  3. Oxford University Press (2)
  4. American Medical Association (1)
  5. John Wiley & Sons, Inc. (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save
  • Can metabolic tumor volume further risk stratify patients eligible for treatment deintensification in the newly proposed HPV-associated oropharyngeal cancer staging system?
    Meeting Abstract

    Romesser, P. B.; Ong, L.; Wong, R. J.; Sherman, E. J.; Riaz, N.; McBride, S. M.; Katabi, N.; Schoder, H.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan
    Journal Article

    Romesser, P. B.; Lim, R.; Spratt, D. E.; Setton, J.; Riaz, N.; Lok, B.; Rao, S.; Sherman, E. J.; Schòˆder, H.; Lee, N. Y.
    Oral Oncology (2014)

    Fulltext@MSK | Save
  • Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma
    Journal Article

    Sherman, E. J.; Su, Y. B.; Lyall, A.; Schoder, H.; Fury, M. G.; Ghossein, R. A.; Haque, S.; Lisa, D.; Shaha, A. R.; Tuttle, R. M.; more...
    Thyroid (2013)

    Fulltext@MSK | Save
  • Target volume delineation in oropharyngeal cancer: Impact of PET, MRI, and physical examination
    Journal Article

    Thiagarajan, A.; Caria, N.; Schoder, H.; Iyer, N. G.; Wolden, S.; Wong, R. J.; Sherman, E.; Fury, M. G.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Tuttle, R. M.; Ghossein, R. A.; Schòˆder, H.; Baum, M. S.; Kelly, K.; Chen, A. P.; Shaha, A. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Primary tumor metabolic volume improves risk prediction of long-term outcomes in patients with oropharyngeal squamous cell carcinoma treated with intensity modulated radiation therapy (IMRT) and chemotherapy
    Meeting Abstract

    Lim, R. C.; Schoder, H.; Eaton, A.; Gonen, M.; Rao, S.; Sherman, E.; Wong, R.; Setton, J.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • A pilot study of using pre- and early (1 week) [18f]-misonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) scans as an early treatment response predictor in a series of head and neck cancer (HNC) patients undergoing chemoradiation
    Meeting Abstract

    Lee, N.; Bartlett, R.; Lian, M.; Fury, M.; Sherman, E.; Wong, R.; Zanzonico, P. B.; Schoder, H.; Humm, J.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap (aflibercept) in patients with radioactive iodine-refractory, positron emission tomography (PET) positive thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Ghossein, R. A.; Lisa, D. M.; Schoder, H.; Baum, M. S.; Shaha, A. R.; Tuttle, R. M.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Target volume delineation in oropharyngeal cancer: Impact of PET, MRI and physical examination
    Meeting Abstract

    Thiagarajan, A.; Caria, N.; Schoder, H.; Iyer, N.; Wolden, S.; Wong, R. J.; Kraus, D. H.; Sherman, E.; Fury, M. G.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save